ACE and kidney disorder: Recently, HOPE trial has also revealed beneficial effects of ACE inhibitors on vascular endothelium resulting in reduction of cardiovascular morbidity and mortality.[30] The implications of this observation on cardiovascular mortality and morbidity, and in future, progression of renal disease in patients with EHT remain to be established.